Refreshing results…
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
UploadOvercoming IMiD Resistance in T-cell Lymphomas Through Potent Degradation of ZFP91 and IKZF1
Download from ashpublications.orgCathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma
Download from doi.orgGenomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions
UploadMissing publications? Search for publications with a matching author name.